Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

So, the FDA lets GSK _re-patent_ the same medication* but just with a new propellant.*

The FDA doesn't control what the patent office approves.



Its techincally not a patent but market exclusivity by the FDA


The patent is worthless if the FDA doesn't approve its use.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: